{
  "retracted": false,
  "timestamp": 1525132800000,
  "updates": [
    {
      "timestamp": 1588876998780,
      "identifier": {
        "doi": "10.1136/annrheumdis-2017-211388corr1"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1136/annrheumdis-2017-211388"
  },
  "publisher": "BMJ",
  "title": "Correction: Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles"
}
